Division of Nephrology & Hypertension, Ma-E19, Mayo Clinic, Rochester, MN 55905, USA.
Phytomedicine. 2011 Jul 15;18(10):863-7. doi: 10.1016/j.phymed.2011.01.018. Epub 2011 Mar 17.
Kidney stones are a common problem for which inadequate prevention exists. We recruited ten recurrent kidney stone formers with documented calcium oxalate stones into a two phased study to assess safety and effectiveness of Cystone(®), an herbal treatment for prevention of kidney stones. The first phase was a randomized double-blinded 12 week cross over study assessing the effect of Cystone(®) vs. placebo on urinary supersaturation. The second phase was an open label one year study of Cystone(®) to determine if renal stone burden decreased, as assessed by quantitative and subjective assessment of CT. Results revealed no statistically significant effect of Cystone(®) on urinary composition short (6 weeks) or long (52 weeks) term. Average renal stone burden increased rather than decreased on Cystone(®). Therefore, this study does not support the efficacy of Cystone(®) to treat calcium oxalate stone formers. Future studies will be needed to assess effects on stone passage, or on other stone types.
肾结石是一种常见的问题,但目前预防措施不足。我们招募了 10 名有草酸钙结石病史的复发性肾结石患者,进行了两阶段研究,以评估 Cystone(®)作为肾结石预防的一种草药治疗的安全性和有效性。第一阶段是一项随机、双盲、12 周交叉研究,评估 Cystone(®)与安慰剂对尿饱和度的影响。第二阶段是一项为期一年的 Cystone(®)开放标签研究,以确定 CT 定量和主观评估的肾石负担是否减少。结果显示,Cystone(®)对短期(6 周)和长期(52 周)尿成分无统计学显著影响。在 Cystone(®)治疗下,平均肾石负担增加而不是减少。因此,本研究不支持 Cystone(®)治疗草酸钙结石形成者的疗效。需要进一步研究来评估其对结石排出或其他结石类型的影响。